For example, Lourenco et al[98] demonstrated that irisin was capable of opposing synapse loss and amnesia in mouse models of AD; this in vitro study suggested that FNDC5/irisin could bind to the unexplored receptors located on the membrane of hippocampal neurons and astrocytes to mediate their beneficial effects. This evidence concerns the gene FNDC5 and Alzheimer disease.